Kedrion's QIVIGY® Receives Orphan Drug Designation for Rare Neurological Disorder#United_States#Fort_Lee,_NJ#Kedrion_Biopharma#QIVIGY#Stiff_Person_Syndrome
Kedrion's QIVIGY® Receives Orphan Drug Designation for Rare Neurological Disorder
Kedrion Biopharma's QIVIGY® has achieved Orphan Drug Designation from the FDA for treating Stiff Person Syndrome, a rare neurological condition.
third-news.com
September 22, 2026 at 1:42 PM
Kedrion's QIVIGY® Receives Orphan Drug Designation for Rare Neurological Disorder#United_States#Fort_Lee,_NJ#Kedrion_Biopharma#QIVIGY#Stiff_Person_Syndrome
Mezzion Pharmaceuticals Welcomes Dr. Ridwan Shabsigh as New COO to Lead Rare Disease Innovations#USA#Fort_Lee,_NJ#JURVIGO#Mezzion#Ridwan_Shabsigh
Mezzion Pharmaceuticals Welcomes Dr. Ridwan Shabsigh as New COO to Lead Rare Disease Innovations
Dr. Ridwan Shabsigh has been appointed as Mezzion Pharmaceuticals' COO, bringing over 35 years of expertise in drug development and clinical research critical for advancing JURVIGO®.
third-news.com
January 6, 2026 at 2:46 PM
Mezzion Pharmaceuticals Welcomes Dr. Ridwan Shabsigh as New COO to Lead Rare Disease Innovations#USA#Fort_Lee,_NJ#JURVIGO#Mezzion#Ridwan_Shabsigh
Kedrion Biopharma's COAGADEX® Receives Orphan Drug Status and Clinical Trial Begins for Rare Blood Disorder#USA#Fort_Lee,_NJ#Kedrion_Biopharma#COAGADEX#aFXD
Kedrion Biopharma's COAGADEX® Receives Orphan Drug Status and Clinical Trial Begins for Rare Blood Disorder
Kedrion Biopharma announces that COAGADEX® has received Orphan Drug Designation from the FDA for acquired Factor X deficiency, with clinical trials underway.
third-news.com
July 29, 2025 at 8:43 PM
Kedrion Biopharma's COAGADEX® Receives Orphan Drug Status and Clinical Trial Begins for Rare Blood Disorder#USA#Fort_Lee,_NJ#Kedrion_Biopharma#COAGADEX#aFXD
Celebrate National Wing Day with Exciting Deals from bb.q Chicken#USA#Fort_Lee,_NJ#Korean_Fried_Chicken#bb.q_Chicken#Milkis
Celebrate National Wing Day with Exciting Deals from bb.q Chicken
Enjoy National Wing Day on July 29 with bb.q Chicken’s massive deal — 15% off and free delivery on orders across the U.S. Don't miss this!
third-news.com
July 23, 2025 at 3:20 PM
Celebrate National Wing Day with Exciting Deals from bb.q Chicken#USA#Fort_Lee,_NJ#Korean_Fried_Chicken#bb.q_Chicken#Milkis
Kedrion Biopharma Enhances Distribution of Ryplazim for PLGD-1 Patients Across the U.S.#United_States#Fort_Lee,_NJ#Kedrion_Biopharma#Ryplazim#PLGD-1
Kedrion Biopharma Enhances Distribution of Ryplazim for PLGD-1 Patients Across the U.S.
Kedrion Biopharma Inc. has expanded the distribution network for Ryplazim, the sole FDA-approved treatment for patients with plasminogen deficiency type 1 (PLGD-1), ensuring better access for all.
third-news.com
March 21, 2025 at 4:10 PM
Kedrion Biopharma Enhances Distribution of Ryplazim for PLGD-1 Patients Across the U.S.#United_States#Fort_Lee,_NJ#Kedrion_Biopharma#Ryplazim#PLGD-1
Legal-Bay Expands Financial Support for Victims of Sexual Harassment Litigation#United_States#Legal-Bay#Sexual_Harassment#Pre-Settlement_Funding#Fort_Lee,_NJ
Legal-Bay Expands Financial Support for Victims of Sexual Harassment Litigation
Legal-Bay LLC announces a new capital allocation for victims of wrongful termination related to sexual harassment claims, addressing urgent financial needs.
third-news.com
February 11, 2025 at 11:49 AM
Legal-Bay Expands Financial Support for Victims of Sexual Harassment Litigation#United_States#Legal-Bay#Sexual_Harassment#Pre-Settlement_Funding#Fort_Lee,_NJ